Novel High-Frequency Peripheral Nerve Stimulator Treatment of Refractory Postherpetic Neuralgia: A Brief Technical Note

2015 ◽  
Vol 18 (6) ◽  
pp. 487-493 ◽  
Author(s):  
Imanuel R. Lerman ◽  
Jeffrey L. Chen ◽  
David Hiller ◽  
Dmitri Souzdalnitski ◽  
Geoffrey Sheean ◽  
...  
Keyword(s):  
Peripheral Nerve ◽  
Postherpetic Neuralgia ◽  
High Frequency ◽  
Technical Note ◽  
Nerve Stimulator ◽  
Peripheral Nerve Stimulator

scholarly journals Techniques for Peripheral Nerve Stimulator Implantation of the Upper Extremity

Pain Medicine ◽  
2020 ◽  
Vol 21 (Supplement_1) ◽  
pp. S27-S31
Author(s):  
Vinita Singh ◽  
Diya Sandhu ◽  
Nan Xiang
Keyword(s):  
Peripheral Nerve ◽  
Upper Extremity ◽  
Nerve Stimulation ◽  
Pulse Generator ◽  
Technical Note ◽  
Peripheral Nerve Stimulation ◽  
Nerve Stimulator ◽  
Peripheral Nerve Stimulator ◽  
Academic Center ◽  
Technical Details

Abstract Objective To present a technical note on how to perform upper extremity peripheral nerve stimulators for three major nerves: median, ulnar, and radial. Design Literature review and expert opinion. Setting Single academic center. Results Peripheral nerve stimulation has recently become popular with the development and availability of peripheral nerve stimulators with an external pulse generator. Here, we describe ultrasound anatomy and technical details for peripheral nerve stimulation in the upper extremity for three major nerves: median, ulnar, and radial. Conclusions Upper extremity peripheral nerve stimulation can be considered as an option for refractory neuropathic upper extremity pain.

Prospective case series on the use of peripheral nerve stimulation for focal mononeuropathy treatment

2019 ◽  
Vol 9 (6) ◽  
pp. 551-558 ◽  
Author(s):  
Jessica Oswald ◽  
Varun Shahi ◽  
Krishnan V Chakravarthy
Keyword(s):  
Peripheral Nerve ◽  
Case Series ◽  
Suprascapular Nerve ◽  
Intercostal Nerve ◽  
Nerve Stimulator ◽  
Patient Case ◽  
Peripheral Nerve Stimulator ◽  
Pain Scores ◽  
Early Results ◽  
Prospective Case Series

Aim: This case series looks at outcomes in 39 patients implanted using the Bioness Stimrouter system on various isolated mononeuropathies. Patients & methods: A case series of 39 patients with a total of 42 implants were enrolled starting August 2017 at various pain management centers. Results: Of 39 patients studied, 78% of the participants noticed an improvement in their pain. There was a 71% reduction in pain scores with the average preprocedure score of 8 improving to 2 post-implant. Participants noted on average a 72% improvement in activity with the greatest observed in the brachial plexus (80%) and suprascapular nerve (80%) and smallest in the intercostal nerve (40%). Approximately 89% of those implanted with a peripheral nerve stimulator experienced a greater than 50% reduction in opioid consumption. Conclusion: Peripheral nerve stimulators are a new, minimally invasive neuromodulation modality that shows promising early results in our 39-patient case series.

Some Hints in Using the Peripheral Nerve Stimulator

1973 ◽  
Vol 52 (3) ◽  
pp. 322
Author(s):  
HENRY ROSENBERG ◽  
JUNE CARTER ◽  
AGNES MacBETH
Keyword(s):  
Peripheral Nerve ◽  
Nerve Stimulator ◽  
Peripheral Nerve Stimulator

scholarly journals A CONSTANT CURRENT PERIPHERAL NERVE STIMULATOR (NEUROSTIM T4)

1986 ◽  
Vol 58 (12) ◽  
pp. 1443-1446 ◽  
Author(s):  
T. POLLMAECHER ◽  
H. STEIERT ◽  
W. BUZELLO
Keyword(s):  
Peripheral Nerve ◽  
Constant Current ◽  
Nerve Stimulator ◽  
Peripheral Nerve Stimulator

A Portable Peripheral Nerve-Stimulator

1965 ◽  
Vol 26 (2) ◽  
pp. 224-226 ◽  
Author(s):  
H. C. CHURCHILL-DAVIDSON
Keyword(s):  
Peripheral Nerve ◽  
Nerve Stimulator ◽  
Peripheral Nerve Stimulator

Block characteristics of Dexmedetomidine as an adjuvant to local anaesthetic in Infraclavicular brachial plexus block using peripheral nerve stimulator and ultrasound

2021 ◽  
Vol 23 (2) ◽  
pp. 40-46
Author(s):  
Ujma Shrestha ◽  
Sushila Lama Moktan ◽  
Sanjay Shrestha
Keyword(s):  
Peripheral Nerve ◽  
Brachial Plexus ◽  
Brachial Plexus Block ◽  
Sensory Block ◽  
Local Anaesthetics ◽  
Nerve Stimulator ◽  
Ultrasound Guided ◽  
Peripheral Nerve Stimulator ◽  
Infraclavicular Brachial Plexus Block ◽  
Plexus Block

Introduction: Dexmedetomidine has been frequently used in regional anaesthesia to improve the quality of blocks. Addition of dexmedetomidine to local anaesthetics has been shown to hasten the onset of both sensory and motor blocks and also prolong the duration of analgesia. The objective of this prospective comparative study was to assess the change in characteristics of infraclavicular brachial plexus block after adding Inj. Dexmedetomidine to 2% Lignocaine with Adrenaline. Methods: Sixty-six patients, scheduled for upper limb surgeries under ultrasound guided infraclavicular brachial plexus block were randomly allocated to two groups. Group LS received Inj. Lignocaine 2% with Adrenaline, 7mg/kg diluted to 30 ml with saline and Group LD received Inj. Dexmedetomidine 0.75 mcg/kg in addition to Inj. Lignocaine 2% with Adrenaline, 7mg/kg again diluted to a total volume of 30 ml. The parameters studied were: onset of sensory and motor blocks and duration of analgesia. Results: Sixty patients completed the study. The demographic variables and motor block were similar between both groups. The mean time to onset of sensory block was significantly faster in Group LD compared to Group LS (9.80±4.85 min vs 12.30±3.97 min, p=0.033). The duration of analgesia was also found to be prolonged in Group LD compared to Group LS (286.73±55.38 min vs 226.53±41.19 min, p < 0.001). Conclusion: Addition of 0.75 mcg/kg of Dexmedetomidine to 2% Lignocaine with Adrenaline hastens the onset of sensory block and prolongs the duration of analgesia in ultrasound guided and peripheral nerve stimulator guided infraclavicular block.

Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU

1996 ◽  
Vol 5 (6) ◽  
pp. 449-454 ◽  
Author(s):  
R Kleinpell ◽  
C Bedrosian ◽  
L McCormick ◽  
M Kremer ◽  
L Bujalski ◽  
...  
Keyword(s):  
Peripheral Nerve ◽  
Neuromuscular Blockade ◽  
National Sample ◽  
Neuromuscular Blocking ◽  
Nerve Stimulator ◽  
Peripheral Nerve Stimulator ◽  
Number Of Patients ◽  
Train Of Four ◽  
Current Monitoring ◽  
Prolonged Neuromuscular Blockade

BACKGROUND: Neuromuscular blockade is a frequently used therapy in the ICU. However, recent reports of prolonged paralysis and general muscular weakness in patients treated with this procedure have raised concerns about its use in intensive care. OBJECTIVE: The purpose of this study was to assess current monitoring practices of nurses who care for patients treated with neuromuscular blockade. METHODS: In January 1995, questionnaires were mailed to a random national sample of 2000 critical care nurses. Of the 2000 questionnaires mailed, 744 were returned. RESULTS: The number of patients per month who were treated with neuromuscular blockade in ICU settings ranged from 0 to 75 (mean = 6.82, SD = 9.15). For each patient, the average number of days of blockade ranged from less than 1 to 63 (mean = 4.12, SD = 3.36). The most common indications for neuromuscular blockade were to assist in mechanical ventilation, reduce oxygen consumption, and treat agitation. Only 41% of respondents (n = 306) reported using train-of-four stimuli and a peripheral nerve stimulator to monitor patients. Depth of neuromuscular blockade was routinely monitored by using clinical assessment (31%), a peripheral nerve stimulator (16%), or both (52%). CONCLUSIONS: Among the respondents, variations existed in monitoring practices and in the use of peripheral nerve stimulators, including the frequency of monitoring and use of the baseline milliamperage. Appropriate monitoring and titration of neuromuscular blocking agents by ICU nurses may aid in preventing adverse effects, including the potential for prolonged neuromuscular blockade. The existing variations in practice may affect patients' outcomes.

Sign in / Sign up

Export Citation Format

Share Document